Fuentes, Jessie Faye M.

HRN: 25-20-43  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/28/2026
CEFTRIAXONE 1G (VIAL)
07/28/2026
08/04/2026
IV
1G
Q12hrs
ORIF PLATING DISTAL RADIUS
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Bone & JointSkin & Soft Tissue    Compliance to guidelines: